港股異動 | 首日上市建中建設(0589.HK)低開高走 現較招股價漲逾26%
格隆匯3月18日丨建中建設(0589.HK)今日上市低開12%,後股價快速拉昇,現報2.09港元,較招股價1.65港元漲26.67%,暫成交1.5億港元,最新總市值13億港元。公司是一家建築服務提供商,專門提供地基工程的一站式解決方案。根據弗若斯特沙利文報告,2018年以收入計算,公司是福建省最大的地基工程分包商及中國第三大非國有地基工程分包商。2016年至2018年收益1.56億、4.98億、11.92億元人民幣。公司此次發售1.56億股,其中香港公開發售6250萬股,香港公開發售獲59.04倍認購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.